Trial Profile
A single-center, randomized, double-blind, placebo controlled trial examining the safety and efficacy of topiramate in the treatment of subjects with episodic or chronic cluster headache
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 24 Jul 2007
Price :
$35
*
At a glance
- Drugs Topiramate (Primary)
- Indications Cluster headache
- Focus Therapeutic Use
- 29 Oct 2005 New trial record.